Gottlieb, R. L., & Kalil, A. C. (2024). True DisCoVeRy of COVID-19 Disease Burden Versus Speculated Antiviral Cardiovascular Risk Requires a Control Group. Clinical Infectious Diseases, 79(2), 392–394. https://doi.org/10.1093/cid/ciae172
Gottlieb, R. L., & Kalil, A. C. (2024). True DisCoVeRy of COVID-19 Disease Burden Versus Speculated Antiviral Cardiovascular Risk Requires a Control Group. Clinical Infectious Diseases, 79(2), 392–394. https://doi.org/10.1093/cid/ciae172